Feedback / Questions
FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus, Teva
https://www.businesswire.com/news/home/20210628005188/en/Teva-and-Bioeq-Announce-Commercial-Partnership-for-Biosimilar
Jun 28, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next